Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Efficacy of Ceritinib After Alectinib for ALK-positive Non-small Cell Lung Cancer.

Yoshida H, Kim YH, Ozasa H, Sakamori Y, Tsuji T, Nomizo T, Yasuda Y, Yamamoto T, Ajimizu H, Hirai T.

In Vivo. 2018 Nov-Dec;32(6):1587-1590. doi: 10.21873/invivo.11418.

2.

Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model.

Tsuji T, Ozasa H, Aoki W, Aburaya S, Funazo T, Furugaki K, Yoshimura Y, Ajimizu H, Okutani R, Yasuda Y, Nomizo T, Uemasu K, Hasegawa K, Yoshida H, Yagi Y, Nagai H, Sakamori Y, Ueda M, Hirai T, Kim YH.

Mol Cancer Res. 2019 Jan;17(1):212-224. doi: 10.1158/1541-7786.MCR-18-0325. Epub 2018 Aug 31.

PMID:
30171175
3.

Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer.

Tsuji T, Sakamori Y, Ozasa H, Yagi Y, Ajimizu H, Yasuda Y, Funazo T, Nomizo T, Yoshida H, Nagai H, Maeno K, Oguri T, Hirai T, Kim YH.

Oncotarget. 2017 May 16;8(42):71805-71816. doi: 10.18632/oncotarget.17895. eCollection 2017 Sep 22.

4.

Pulmonary Tumor Thrombotic Microangiopathy Caused by a Parotid Tumor: Early Antemortem Diagnosis and Long-term Survival.

Toyonaga H, Tsuchiya M, Sakaguchi C, Ajimizu H, Nakanishi Y, Nishiyama S, Morikawa N, Hayashi Y, Nagasaka Y, Yasui H.

Intern Med. 2017;56(1):67-71. doi: 10.2169/internalmedicine.56.7439. Epub 2017 Jan 1.

5.

Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: A case report.

Shima H, Ozasa H, Tsuji T, Ajimizu H, Nomizo T, Yagi Y, Sakamori Y, Nagai H, Minamiguchi S, Kim YH, Mishima M.

Mol Clin Oncol. 2016 May;4(5):715-718. Epub 2016 Mar 7.

6.

Successful treatment with carboplatin and nanoparticle albumin-bound paclitaxel in a patient with pulmonary spindle cell carcinoma.

Tsuji T, Kim YH, Ozasa H, Sakamori Y, Nagai H, Ajimizu H, Yagi Y, Furukawa A, Haga H, Mishima M.

Respir Med Case Rep. 2015 May 15;15:48-50. doi: 10.1016/j.rmcr.2015.05.003. eCollection 2015.

7.

Rapid response of brain metastases to alectinib in a patient with non-small-cell lung cancer resistant to crizotinib.

Ajimizu H, Kim YH, Mishima M.

Med Oncol. 2015 Feb;32(2):477. doi: 10.1007/s12032-014-0477-7. Epub 2015 Jan 3.

PMID:
25556163

Supplemental Content

Loading ...
Support Center